Skip to main content

and
  1. Article

    Open Access

    A phase I/II clinical trial on the efficacy and safety of NKT cells combined with gefitinib for advanced EGFR-mutated non-small-cell lung cancer

    Epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs), such as gefitinib, have achieved good efficacy in EGFR mutation-positive non-small-cell lung cancer (NSCLC) patients, but eventual drug ...

    Wanjun Yu, Fei Ye, **ao Yuan, Yali Ma, Chaoming Mao, **aoqin Li, Jian Li in BMC Cancer (2021)

  2. No Access

    Article

    A genome-wide association study identifies two new cervical cancer susceptibility loci at 4q12 and 17q12

    Ding Ma, **ng **e, Yongyong Shi and colleagues report a genome-wide association study of cervical cancer in the Han Chinese population. They identify two new susceptibility lociat 4q12 and 17q12.

    Yongyong Shi, Li Li, Zhibin Hu, Shuang Li, Shixuan Wang, Jihong Liu in Nature Genetics (2013)